Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis. Brastianos PK, Lee EQ, Cohen JV, Tolaney SM, et al. Nat Med 2020;26:1280-1284.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Brastianos PK, Lee EQ, Cohen JV, Tolaney SM, et al. Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis. Nat Med 2020;26:1280-1284.
PMID: 32483359